Co-Diagnostics receives emergency use authorisation for Covid-19 test

Co-Diagnostics’ Covid-19 test uses its CoPrimer technology to target the RdRp gene of the SARS-CoV-2 virus. Credit: Co-Diagnostics.Inc.